Technical Analysis for SCPH - scPharmaceuticals Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 1.75% | |
| Pocket Pivot | Bullish Swing Setup | 1.75% | |
| Volume Surge | Other | 1.75% | |
| Bollinger Band Squeeze | Range Contraction | 1.75% | |
| Wide Range Bar | Range Expansion | 1.75% | |
| New 52 Week Low | Weakness | 1.75% | |
| Earnings Movers | Other | 1.75% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 1.75% | |
| Outside Day | Range Expansion | 1.75% | |
| Gapped Down | Weakness | 1.75% |
| Alert | Time |
|---|---|
| Rose Above 20 DMA | 3 minutes ago |
| Rose Above 10 DMA | 3 minutes ago |
| Up 2% | 3 minutes ago |
| Up 1% | 3 minutes ago |
| 20 DMA Resistance | about 22 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/14/2024
scPharmaceuticals Inc. Description
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Drugs Medication Pharmaceutical Products Chemical Compounds Antibiotics Heart Failure Chloroarenes Injection Intravenous Fluids Intravenous Therapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.75 |
| 52 Week Low | 4.0094 |
| Average Volume | 223,313 |
| 200-Day Moving Average | 5.91 |
| 50-Day Moving Average | 4.92 |
| 20-Day Moving Average | 4.58 |
| 10-Day Moving Average | 4.64 |
| Average True Range | 0.32 |
| RSI (14) | 46.52 |
| ADX | 15.97 |
| +DI | 12.36 |
| -DI | 24.93 |
| Chandelier Exit (Long, 3 ATRs) | 4.02 |
| Chandelier Exit (Short, 3 ATRs) | 4.97 |
| Upper Bollinger Bands | 4.84 |
| Lower Bollinger Band | 4.31 |
| Percent B (%b) | 0.49 |
| BandWidth | 11.72 |
| MACD Line | -0.10 |
| MACD Signal Line | -0.11 |
| MACD Histogram | 0.0138 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.74 | ||||
| Resistance 3 (R3) | 5.68 | 5.24 | 5.55 | ||
| Resistance 2 (R2) | 5.24 | 4.94 | 5.27 | 5.48 | |
| Resistance 1 (R1) | 4.90 | 4.75 | 5.07 | 4.96 | 5.42 |
| Pivot Point | 4.46 | 4.46 | 4.54 | 4.48 | 4.46 |
| Support 1 (S1) | 4.12 | 4.16 | 4.29 | 4.18 | 3.72 |
| Support 2 (S2) | 3.68 | 3.97 | 3.70 | 3.66 | |
| Support 3 (S3) | 3.34 | 3.68 | 3.59 | ||
| Support 4 (S4) | 3.40 |
